rofecoxib has been researched along with Arrhythmias, Cardiac in 4 studies
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiac adverse effects are among the leading causes of the discontinuation of clinical trials and the withdrawal of drugs from the market." | 5.56 | Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. ( Baczkó, I; Baranyai, T; Brenner, GB; Ferdinandy, P; Gergely, TG; Giricz, Z; Görbe, A; Husti, Z; Kiss, B; Lázár, B; Makkos, A; Nagy, CT; Onódi, Z; Sághy, É; Sayour, NV; Schulz, R; Tóthfalusi, L; Varga, RS; Varró, A; Zádori, ZS, 2020) |
| "Cardiac adverse effects are among the leading causes of the discontinuation of clinical trials and the withdrawal of drugs from the market." | 1.56 | Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. ( Baczkó, I; Baranyai, T; Brenner, GB; Ferdinandy, P; Gergely, TG; Giricz, Z; Görbe, A; Husti, Z; Kiss, B; Lázár, B; Makkos, A; Nagy, CT; Onódi, Z; Sághy, É; Sayour, NV; Schulz, R; Tóthfalusi, L; Varga, RS; Varró, A; Zádori, ZS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, GB | 1 |
| Makkos, A | 1 |
| Nagy, CT | 1 |
| Onódi, Z | 1 |
| Sayour, NV | 1 |
| Gergely, TG | 1 |
| Kiss, B | 1 |
| Görbe, A | 1 |
| Sághy, É | 1 |
| Zádori, ZS | 1 |
| Lázár, B | 1 |
| Baranyai, T | 1 |
| Varga, RS | 1 |
| Husti, Z | 1 |
| Varró, A | 1 |
| Tóthfalusi, L | 1 |
| Schulz, R | 1 |
| Baczkó, I | 1 |
| Giricz, Z | 1 |
| Ferdinandy, P | 1 |
| Khamsi, R | 1 |
| Eggertson, L | 1 |
4 other studies available for rofecoxib and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiotoxicity; Cell Survival; | 2020 |
Painkiller in the dock.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arrhythmias, Cardiac; Drug Industry; Humans; Lactones; Legi | 2005 |
Painkiller verdict shows mistrust of Merck.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Disclosure; Drug Industry; Humans; Lactones; Male; Su | 2005 |
Vioxx award good news for Canadian lawsuits.
Topics: Arrhythmias, Cardiac; Cyclooxygenase Inhibitors; Drug Industry; Humans; Lactones; Liability, Legal; | 2005 |